RxDoctor Payments Data

Taraneh Azar, MD

Otolaryngology · Portsmouth, NHNPI 1043289739

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,195 of the $3,849 with a category attached, or 83.0%. It is spread thinly across 19 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Among otolaryngology clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,849in general payments, 2019–2025

Across 103 payments — averaging $37.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$795
  • Aerin Medical Inc.$683
  • GSK$588
  • Sanofi$564
  • Regeneron Healthcare Solutions, Inc.$373
  • Intersect ENT, Inc.$191
  • plus $657 from 13 others

What the payments were for

  • Speaking & faculty fees$50013%
  • Food & beverage$3,19583%
  • Education$1544%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,849 in reported general payments places this provider in the 90th percentile of 44 otolaryngology providers in New Hampshire.

See all otolaryngology providers in New Hampshire

Medicare billing

Part B allowed, 2024
$229,973
Medicare patients
768
Services billed
2,163

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine221$4,227
Ipratropium Bromide71$1,937
Levothyroxine Sodium98$1,044
Mometasone Furoate22$669
Pantoprazole Sodium19$468
Fluticasone Propionate19$419
Omeprazole68$300
Cephalexin19$256
Oxycodone Hcl20$148
Gabapentin21$86
Prednisone15$49

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Portsmouth

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →